Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAura Renew Acq Regulatory News (ARA)

Share Price Information for Aura Renew Acq (ARA)

Share Price is delayed by 15 minutes
Get Live Data
2.50    0.00 (0.00%)
Bid:
1.50
Ask:
3.50
Spread: 2.00 (133.333%)
Market Cap: £262.50k
ARA Live PriceLast checked at - London Stock Exchange

Intraday Aura Renew Acq Share Chart

Director/PDMR Shareholding

13 Dec 2007 17:14

Ardana PLC13 December 2007 Annex DTR3 NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGINGMANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS All relevant boxes should be completed in block capital letters. 1. Name of the issuer Ardana PLC 2. State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006). DTR 3.1.2R 3. Name of person discharging managerial responsibilities/director JOHN GRAHAM LEE 4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A 5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest(1) N/A 6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares N/A 7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them N/A 8. State the nature of the transaction N/A 9. Number of shares, debentures or financial instruments relating to shares acquired N/A 10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A 11. Number of shares, debentures or financial instruments relating to shares disposed N/A 12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A 13. Price per share or value of transaction N/A 14. Date and place of transaction N/A 15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A 16. Date issuer informed of transaction N/A If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes 17. Date of grant 13 DECEMBER 2007 18. Period during which or date on which exercised 13 DECEMBER 2010 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) ORDINARY £0.01P SHARE - 100,000 21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise £0.47P 22. Total number of shares or debentures over which options held following notification 341,714 23. Any additional information GRANT APPROVED BY BOARD 12 DECEMBER 2007 24. Name of contact and telephone number for queries GRAHAM LEE - 0131 226 8550 Name of authorised officer of issuer responsible for making notification Date of notification 13 DECEMBER 2007 Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3. (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11,13, 14, 16, 23 and 24. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Apr 20072:41 pmRNSHolding(s) in Company
21st Mar 20073:00 pmRNSHolding(s) in Company
19th Mar 20076:21 pmRNSHolding(s) in Company
13th Mar 200712:00 pmRNSHolding(s) in Company
28th Feb 20072:58 pmRNSVoting Rights
14th Feb 20077:00 amRNSResearch Update
13th Feb 20077:01 amRNSRe Agreement
21st Dec 20067:00 amRNSTotal Voting Rights
19th Dec 20067:01 amRNSProduct Launch
19th Dec 20067:01 amRNSResearch Update
19th Dec 20067:01 amRNSInterim Results
12th Dec 20067:01 amRNSNotice of Results
16th Nov 20067:01 amRNSProduct Launch
2nd Nov 20062:09 pmRNSBlocklisting Interim Review
20th Oct 20065:37 pmRNSHolding(s) in Company
19th Oct 20063:10 pmRNSHolding(s) in Company
16th Oct 20065:40 pmRNSHolding(s) in Company
13th Oct 200610:34 amRNSDirector/PDMR Shareholding
12th Oct 20061:33 pmRNSEGM Statement
12th Oct 20067:46 amRNSResult of Placing
11th Oct 20061:51 pmRNSAGM Statement
28th Sep 200611:16 amRNSAnnual Information Update
20th Sep 20067:03 amRNSIssue of Equity
13th Sep 200611:40 amRNSAnnual Report and Accounts
11th Sep 20067:01 amRNSResearch Update
7th Sep 20067:02 amRNSResearch Update
31st Aug 20067:01 amRNSUS Patent for Teverelix LA
29th Jun 20067:02 amRNSFinal Results
29th Jun 20067:01 amRNSNon-Executive Director
14th Jun 20064:44 pmRNSNotice of Results
16th May 20064:17 pmRNSHolding(s) in Company
12th May 200612:19 pmRNSHolding(s) in Company
3rd May 20063:26 pmRNSAdditional Listing
12th Apr 20067:01 amRNSResearch Update
17th Mar 20067:02 amRNSAppointment
16th Mar 20063:10 pmRNSHolding(s) in Company
14th Mar 20065:41 pmRNSHolding(s) in Company
31st Jan 20067:01 amRNSFDA Update
13th Dec 20057:00 amRNSInterim Results
9th Nov 20057:00 amRNSRe Agreement
31st Oct 20057:00 amRNSResearch Update
28th Oct 20059:47 amRNSHolding(s) in Company
5th Oct 20057:00 amRNSStriant Germany Launch
27th Sep 20051:31 pmRNSHolding(s) in Company
21st Sep 200512:30 pmRNSDirector/PDMR Shareholding
21st Sep 20057:00 amRNSResearch Update
30th Aug 20057:00 amRNSChange of Adviser
29th Jun 20057:00 amRNSFinal Results
17th Jun 20057:58 amRNSNon-executive appointment
16th Jun 20057:01 amRNSRe Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.